Long-term survival and quality of life assessment after allogeneic stem cell transplantation for haematological malignancies; comparable results following myeloablative and reduced-intensity conditioning

被引:0
|
作者
Shimoni, A. [1 ]
Tallis, E. [1 ]
Shem-Tov, N. [1 ]
Volchek, Y. [1 ]
Yerushalmi, R. [1 ]
Nagler, A. [1 ]
机构
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S51 / S52
页数:2
相关论文
共 50 条
  • [1] Long-Term Survival and Quality of Life Assessment After Allogeneic Stem-Cell Transplantation; Comparable Results Following Myeloablative and Reduced-Intensity Conditioning
    Shimoni, Avichai
    Tallis, Eran
    Shem-Tov, Noga
    Volchek, Yulia
    Yerushalmi, Ronit
    Nagler, Arnon
    [J]. BLOOD, 2011, 118 (21) : 1749 - 1749
  • [2] LONG-TERM SURVIVAL AND QUALITY OF LIFE (QOL) ASSESSMENT AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION (SCT) FOR ACUTE LEUKEMIA AND MDS; COMPARABLE RESULTS WITH MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING
    Shimoni, A.
    Talus, E.
    Rand, A.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S177 - S177
  • [3] Long-term survival and late events after allogeneic stem cell transplantation for acute leukaemia and MDS: comparable results with myeloablative and reduced-intensity conditioning
    Shimoni, A.
    Rand, A.
    Shem-Tov, N.
    Hardan, I.
    Volchek, Y.
    Maayaan, H.
    Yerushalmi, R.
    Nagler, A.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S59 - S59
  • [4] Long-Term Survival and Late Events After Allogeneic Stem-Cell Transplantation with Reduced-Intensity Conditioning (RIC) for AML and Mds; Comparable Results with Myeloablative Conditioning
    Shimoni, Avichai
    Rand, Avitat
    Shem-Tov, Noga
    Hardan, Izhar
    Volchek, Yulia
    Maayaan, Hannah
    Yerushalmi, Ronit
    Nagler, Arnon
    [J]. BLOOD, 2009, 114 (22) : 214 - 215
  • [5] Long-term complications and quality of life after reduced-intensity conditioning allogeneic stem cell transplantation
    Clavert, A.
    Peric, Z.
    Cahu, X.
    Chevallier, P.
    Brissot, E.
    Malard, F.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Harousseau, J-L.
    Moreau, P.
    Milpied, N.
    Mohty, M.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S52 - S52
  • [6] LONG-TERM SURVIVAL AND QUALITY OF LIFE (QoL) ASSESSMENT AFTER REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM-CELL TRANSPLANTATION (SCT) FOR HEMATOLOGICAL MALIGNANCIES
    Shimoni, A.
    Tallis, E.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S227 - S227
  • [7] Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies
    A. Sureda
    N. Schmitz
    [J]. Annals of Hematology, 2003, 82 : 1 - 13
  • [8] Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies
    Sureda, A
    Schmitz, N
    [J]. ANNALS OF HEMATOLOGY, 2003, 82 (01) : 1 - 13
  • [9] Long-term results of allogeneic stem cell transplantation after reduced-intensity conditioning regimen fludarabin, busulfan and ATG
    Brychtova, Y.
    Krejci, M.
    Muzik, J.
    Doubek, M.
    Mayer, J.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S294 - S294
  • [10] Second Malignancies after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning: Is the Incidence Reduced?
    Shimoni, Avichai
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1669 - 1670